International study to improve treatments for Duchenne muscular dystrophy launched

Automated News - Automated News

Friday, 03 September 2010 08:27

A large international study aimed at improving the care of muscular dystrophy patients worldwide is being launched by physicians, physical therapists, and researchers at the University of Rochester Medical Center.

Read more: Yahoo! News Search Results for Multiple Myeloma

ImmunoCellular Therapeutics Issues Letter to Shareholders

Automated News - Automated News

Friday, 03 September 2010 08:15

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics (OTCBB: IMUC) issued the following Letter to Shareholders today: Dear Shareholders, As the summer comes to a close, I wanted to update you on the Company’s accomplishments this year, which set the stage for an exciting fall. The first eight months of the year have been very successful, with the Company attaining many of its goals, despite ...

Read more: Yahoo! News Search Results for Multiple Myeloma

Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID

Automated News - Automated News

Friday, 03 September 2010 08:13

Celgene Corporation today announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration. The application requests authorization to manufacture and market generic versions of REVLIMID (lenalidomide) 5, 10, 15 and 25 mg capsules in the United States.

Read more: Yahoo! News Search Results for Multiple Myeloma

Cardiogenesis Corporation releases comment on STAR-heart study

Automated News - Automated News

Friday, 03 September 2010 07:57

Cardiogenesis Corporation, released comments today regarding the STAR-heart study.The STAR-heart study, which was presented at the European Society of Cardiology 2010 Congress in August 2010, reported that the intracoronary injection of autologous stem cells derived from bone marrow is associated with improved hemodynamics and long term survival in the treatment of chronic heart failure.

Read more: Yahoo! News Search Results for Multiple Myeloma

Celgene Officially Notified of ANDA Filing for REVLIMID®

Automated News - Automated News

Friday, 03 September 2010 07:30

SUMMIT, N.J.----Celgene Corporation today announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application to the U.S.

Read more: Yahoo! News Search Results for Multiple Myeloma

GBI Research's report analyzes licensing agreement to shape global market

Automated News - Automated News

Friday, 03 September 2010 06:28

ReportsandReports announces it will carry the Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma Market Research Report in its store.

Read more: Yahoo! News Search Results for Multiple Myeloma

Santhera, Ipsen partner to develop and commercialize fipamezole outside North America and Japan

Automated News - Automated News

Friday, 03 September 2010 02:42

Santhera Pharmaceuticals and Ipsen today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan. This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease.

Read more: Yahoo! News Search Results for Multiple Myeloma

Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple ...

Automated News - Automated News

Thursday, 02 September 2010 07:29

ReportsandReports announces it will carry the Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma Market Research Report in its store.

Read more: Yahoo! News Search Results for Multiple Myeloma

Cellerant Therapeutics signs contract with BARDA to develop CLT-008 therapy for ARS

Automated News - Automated News

Thursday, 02 September 2010 06:27

Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has signed a contract valued at up to $153 million over five years with the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response ...

Read more: Yahoo! News Search Results for Multiple Myeloma

ESC releases new Clinical Practice Guidelines for management of Grown-up Congenital Heart Disease

Automated News - Automated News

Thursday, 02 September 2010 04:12

The European Society of Cardiology (ESC) today announces the release of new Clinical Practice Guidelines covering the management of Grown-up Congenital Heart Disease (GUCH). More than two million adults in Europe are assumed to be affected by the condition, and the numbers are growing as a consequence of sharply increased survival rates due to advances in paediatric cardiology and heart surgery.

Read more: Yahoo! News Search Results for Multiple Myeloma

Welcome home, Mallika Sherawat

Automated News - Automated News

Thursday, 02 September 2010 01:56

Here's what your favourite celebrities have been up to.

Read more: Yahoo! News Search Results for Multiple Myeloma

Health digest: Unforgettable Tuesday's Day Club and more

Automated News - Automated News

Thursday, 02 September 2010 00:20

The Unforgettable Tuesday's Day Club is held at the community room of Greggton United Methodist Church from 10 a.m. to 2 p.m. each Tuesday. The club provides a secure reprieve for caregivers of people diagnosed with dementia or Alzheimer's disease.

Read more: Yahoo! News Search Results for Multiple Myeloma

Summer office hours have been extended. The office and hotline will close at 2:00 PM Pacific Time on Fridays until the end of September.

Automated News - Automated News

Thursday, 02 September 2010 00:00

Read more: IMF - Home Page

Lisa Ray launches cancer hospital in Mumbai

Automated News - Automated News

Wednesday, 01 September 2010 18:08

Dressed in an off-shoulder figure-hugging grey dress, Lisa Ray would have seemed like an unlikely face at a cancer institute. Ray who has recovered from multiple myeloma flew down from her hometown in Toronto, to launch Fortis Hospitals' cancer institute in Mumbai's eastern suburb of Mulund.

Read more: Yahoo! News Search Results for Multiple Myeloma

Jack Aiello named IMF Advocate of the Month!!

Automated News - Automated News

Wednesday, 01 September 2010 00:00

Congratulations and THANK YOU to Jack Aiello, support group leader and patient from the Bay area for being this month's Advocate of the Month!

Read more: IMF - Home Page

With the help of IMFer Cathy Goetz' testimony, the oral-parity bill has passed in California.

Automated News - Automated News

Wednesday, 01 September 2010 00:00

The next stop is Governor Schwarzenegger!

Read more: IMF - Home Page

Reportlinker Adds Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid ...

Automated News - Automated News

Tuesday, 31 August 2010 12:45

NEW YORK , Aug. 31 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Epigenetics Therapeutics to 2017 â High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma http://www.reportlinker.com/p0286300/Epigenetics-Therapeutics-to-2017-â-High-Market-Potential-for ...

Read more: Yahoo! News Search Results for Multiple Myeloma

Natco files ANDA for generic cancer drug

Automated News - Automated News

Tuesday, 31 August 2010 11:08

Drug maker Natco Pharma today said it has sought the US health regulator's nod to sell lenalidomide capsules, used in treating cancer, in the American market.

Read more: Yahoo! News Search Results for Multiple Myeloma

ESC issues revised practice guidelines for management of AF

Automated News - Automated News

Tuesday, 31 August 2010 08:33

The European Society of Cardiology today issued revised practice guidelines for the management of atrial fibrillation, including guidance on the role of a novel oral treatment, dabigatran etexilate, for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Read more: Yahoo! News Search Results for Multiple Myeloma

Taking Aim At Pre-Leukemia Disorders: NewYork-Presbyterian/Columbia Establishes Myelodysplastic Syndromes Center

Automated News - Automated News

Tuesday, 31 August 2010 07:18

NewYork-Presbyterian Hospital/Columbia University Medical Center has established a new center devoted to research and treatment of pre-leukemia blood disorders. Known as the Myelodysplastic Syndromes Center, it is one of the largest programs of its kind in the nation. Myelodysplastic syndromes (MDS) are disorders interfering with blood production in the bone marrow...

Read more: Yahoo! News Search Results for Multiple Myeloma

Natco Pharma files ANDA for generic Revlimid

Automated News - Automated News

Tuesday, 31 August 2010 03:27

Natco Pharma, a Hyderabad based pharma major with net sales of over Rs 390 crore, has filed an abbreviated new drug application with the US FDA for approval to market lenalidomide capsules in 5, 10, 15 and 25 mg strengths prior to the expiration of various US patents.

Read more: Yahoo! News Search Results for Multiple Myeloma